Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Kontafarma China Holdings Ltd ( (HK:1312) ) is now available.
Kontafarma China Holdings Ltd announced a delay in the dispatch of a circular related to a discloseable and connected transaction concerning the Beijing Construction Contract for the Beijing R&D Complex Project. The delay is due to the need for additional time to finalize certain information, and the company is seeking a waiver from the Stock Exchange to extend the dispatch date to on or before 30 September 2025.
More about Kontafarma China Holdings Ltd
Average Trading Volume: 1,162,576
Technical Sentiment Signal: Sell
Current Market Cap: HK$156.2M
For detailed information about 1312 stock, go to TipRanks’ Stock Analysis page.